Encora Therapeutics is developing a wearable device that utilizes real-time signal processing to deliver personalized vibro-tactile stimulation to the wrist, effectively counteracting hand tremors associated with neurodegenerative movement disorders like Parkinson's disease. This non-invasive technology not only alleviates tremors but also enables continuous monitoring of disease progression for improved patient care.
Funding
Funding not disclosed
HEFounders
Product
Problem
Individuals with neurodegenerative movement disorders, such as Parkinson's disease and essential tremor, often experience debilitating hand tremors that impact their daily activities and quality of life. Current treatment options have limitations, including side effects and the need for invasive procedures.
Solution
Encora Therapeutics is developing a non-invasive wearable device that utilizes real-time signal processing to deliver personalized vibro-tactile stimulation to the wrist, effectively reducing hand tremors. The device employs advanced algorithms to sense tremor severity and introduce dynamic, customized vibratory stimulus, acting as a "noise-canceling" mechanism. By continuously monitoring motor symptoms, the technology also enables real-time tracking of disease progression, facilitating optimized and personalized care. The discreet and user-friendly design promotes patient independence and adherence to therapy.
Target Audience
The primary target audience includes individuals diagnosed with neurodegenerative movement disorders, such as Parkinson's disease and essential tremor, who experience hand tremors.
Features
- Real-time tremor sensing via integrated sensors
- Personalized vibro-tactile stimulation delivered to the wrist
- Adaptive algorithms that adjust stimulation based on tremor severity
- Continuous monitoring of motor symptoms for disease progression tracking
- Wireless connectivity for data logging and remote monitoring
- User-friendly mobile app for device control and data visualization